These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 27276223)
1. Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides. van Santen S; Roach RE; van Doorn R; Horváth B; Bruijn MS; Sanders CJ; de Pooter JC; van Rossum MM; de Haas ER; Veraart JC; Bekkenk MW; Vermeer MH; Willemze R JAMA Dermatol; 2016 Sep; 152(9):992-1000. PubMed ID: 27276223 [TBL] [Abstract][Full Text] [Related]
2. Association of a Proposed New Staging System for Folliculotropic Mycosis Fungoides With Prognostic Variables in a US Cohort. Charli-Joseph Y; Kashani-Sabet M; McCalmont TH; Kornak J; Allen I; Ai WZ; LeBoit PE; Pincus LB JAMA Dermatol; 2021 Feb; 157(2):157-165. PubMed ID: 33295938 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides. Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243 [TBL] [Abstract][Full Text] [Related]
4. New insights into folliculotropic mycosis fungoides (FMF): A single-center experience. Hodak E; Amitay-Laish I; Atzmony L; Prag-Naveh H; Yanichkin N; Barzilai A; Kershenovich R; Feinmesser M J Am Acad Dermatol; 2016 Aug; 75(2):347-55. PubMed ID: 27245278 [TBL] [Abstract][Full Text] [Related]
5. Folliculotropic mycosis fungoides: clinical and epidemiological evaluation in a single center in Brazil. Deonizio JM; Ascef RD; Sanches JA Int J Dermatol; 2016 May; 55(5):e256-61. PubMed ID: 26711732 [TBL] [Abstract][Full Text] [Related]
7. Folliculotropism Does Not Affect Overall Survival in Mycosis Fungoides: Results from a Single-Center Cohort and Meta-Analysis. Giberson M; Mourad A; Gniadecki R Dermatology; 2017; 233(4):320-325. PubMed ID: 29169156 [TBL] [Abstract][Full Text] [Related]
8. Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients. van Santen S; Jansen PM; Quint KD; Vermeer MH; Willemze R J Cutan Pathol; 2020 Mar; 47(3):241-250. PubMed ID: 31755567 [TBL] [Abstract][Full Text] [Related]
9. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors and Survival Outcomes Among Patients With Mycosis Fungoides in China: A 12-Year Review. Chen Z; Lin Y; Qin Y; Qu H; Zhang Q; Li Y; Wen Y; Sun J; Tu P; Gao P; Wang Y JAMA Dermatol; 2023 Oct; 159(10):1059-1067. PubMed ID: 37585188 [TBL] [Abstract][Full Text] [Related]
12. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement. Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999 [TBL] [Abstract][Full Text] [Related]
13. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas. Quaglino P; Pimpinelli N; Berti E; Calzavara-Pinton P; Alfonso Lombardo G; Rupoli S; Alaibac M; Bottoni U; Carbone A; Fava P; Fimiani M; Mamusa AM; Titli S; Zinzani PL; Bernengo MG; Cancer; 2012 Dec; 118(23):5830-9. PubMed ID: 22674564 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880 [TBL] [Abstract][Full Text] [Related]
15. Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. van Doorn R; Scheffer E; Willemze R Arch Dermatol; 2002 Feb; 138(2):191-8. PubMed ID: 11843638 [TBL] [Abstract][Full Text] [Related]
16. Immune privilege disruption in folliculotropic mycosis fungoides: investigation of major histocompatibility complex antigen expression. Deonizio JMD; Guitart J; Yazdan P; Mulinari-Brenner F; Sotto MN; Sanches JA Int J Dermatol; 2018 Jun; 57(6):675-680. PubMed ID: 29603194 [TBL] [Abstract][Full Text] [Related]
17. Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group. van Santen S; van Doorn R; Neelis KJ; Daniëls LA; Horváth B; Bruijn MS; Sanders CJG; van Rossum MM; de Haas ERM; Veraart JCJM; Bekkenk MW; Vermeer MH; Willemze R Br J Dermatol; 2017 Jul; 177(1):223-228. PubMed ID: 28132406 [TBL] [Abstract][Full Text] [Related]
18. Folliculotropic T-cell infiltrates associated with B-cell chronic lymphocytic leukaemia or MALT lymphoma may reveal either true mycosis fungoides or pseudolymphomatous reaction: seven cases and review of the literature. Ingen-Housz-Oro S; Franck N; Beneton N; Fauconneau A; Do-Pham G; Carlotti A; Petit T; Liolios I; Bara C; Carpentier H; Storelli D; Prophette B; Garderet L; Haioun C; Petit E; Delfau-Larue MH; Vergier B; Chosidow O; Beylot-Barry M; Ortonne N J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):77-85. PubMed ID: 24646004 [TBL] [Abstract][Full Text] [Related]